Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
30.11.23
/
50%
€22.00
Target price
30.11.24
€45.85
Performance (%)
6.55%
Price
22:26
€23.44
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.55%. This prediction currently runs until 30.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -4.082% | -4.082% |
iShares Core DAX® | 0.786% | -0.427% |
iShares Nasdaq 100 | 2.297% | 7.331% |
iShares Nikkei 225® | 3.076% | 3.279% |
iShares S&P 500 | 0.902% | 3.970% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $50.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.40
07.02.24
07.02.24
€46.44
07.02.25
07.02.25
-20.27%
22:26
22:26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.94
16.01.24
16.01.24
€45.92
16.01.25
16.01.25
-26.61%
22:26
22:26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.74
08.08.24
08.08.24
-6.50%
22:26
22:26